BIIL 284 BS

DRUG6 trials

Sponsors

Boehringer Ingelheim

Conditions

AsthmaHealthyHepatic InsufficiencyPulmonary Disease, Chronic Obstructive

Phase 1

Pharmacokinetics, Safety and Tolerability of BIIL 284 BS in Patients With Hepatic Impairment in Comparison to Healthy Volunteers

CompletedNCT02265627

Boehringer IngelheimHepatic Insufficiency

Start: 2000-03-31Updated: 2014-10-16

Study to Evaluate the Effect of Multiple Doses of BIIL 284 BS on the Pharmacokinetics of Prednisone in Healthy Male Subjects

CompletedNCT02268149

Boehringer IngelheimHealthy

Start: 2000-04-30Updated: 2014-10-20

Effect of Different Food Compositions on Bioavailability of BIIL 284 BS in Healthy Male Volunteers

CompletedNCT02273427

Boehringer IngelheimHealthy

Start: 2000-02-29Updated: 2014-10-24

Effect of BIIL 284 BS on the Pharmacokinetics of Theophylline in Healthy Male Volunteers

CompletedNCT02273440

Boehringer IngelheimHealthy

Start: 2000-05-31Updated: 2014-10-24

Phase 2

Effect of BIIL 284 BS on Patients With Chronic Obstructive Pulmonary Disease (COPD)

CompletedNCT02249338

Boehringer IngelheimPulmonary Disease, Chronic Obstructive

Start: 1999-10-31Updated: 2014-09-26

The Effect of BIIL 284 BS on Induced-sputum Variables in Patients With Bronchial Asthma

CompletedNCT02249312

Boehringer IngelheimAsthma

Start: 1999-07-31Updated: 2014-09-26